Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities

Summary

This study compares the efficacy and safety of sulodexide (Vessel) to placebo in patients with chronic venous disease of the lower extremities. The primary hypothesis is that more patients will achieve a decrease in rVCSS score of at least 4 points with sulodexide than with placebo.

Timeline

Start

2021-11-25

Primary completion

2023-12

Completion

2023-12

Drugs

Indications